Email Alert RSS
Volume 13 Issue 5
Sep.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
ZHAO Lidan, MENG Xia, XU Haojie, ZHANG Fengchun. Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 740-746. DOI: 10.12290/xhyxzz.2022-0245
Citation: ZHAO Lidan, MENG Xia, XU Haojie, ZHANG Fengchun. Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 740-746. DOI: 10.12290/xhyxzz.2022-0245
shu

Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control

  • Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Education Key Laboratory, Beijing 100730, China

Funds: 

National Natural Science Foundation of China 82071840

CAMS Innovation Fund for Medical Sciences 2020-I2M-C & T-B-013

More Information
  • Corresponding author:

    ZHANG Fengchun, E-mail: zhangfccra@aliyun.com

  • Received Date: May 01, 2022
  • Accepted Date: July 14, 2022
  • Available Online: July 27, 2022
  • Issue Publish Date: September 29, 2022
    Graphical Abstract
    • Abstract
  • Gut microbiota is indispensable for the maintenance of human immune homeostasis. Dysbiosis and translocation of gut microbes as well as aberrance of microbiome metabolites, which are commonly seen in many autoimmune diseases, are suggested to participate in the breakdown of immune tolerance and the excessive inflammatory responses. The involved mechanisms include immune equilibrium skewing, molecular mimicry, bystander activation and epitope spreading, which contributes to the initiation and progression of autoimmune diseases. In addition, the microbial biotransformation of antirheumatic drugs help determine the bioactivity and toxicity of these drugs. Herein, gut microbiota-based intervention may shed light on developing novel strategies for prophylaxis and treatment of autoimmune diseases. In this review, recent advances in exploring the potential pathogenic role of gut microbiota in autoimmunity are summarized and the prospect of applying microbiota-based intervention in systemic autoimmune diseases is addressed.
    • FullText(HTML)
    • References (60)
  • [1]
    Hevia A, Milani C, López P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus[J]. mBio, 2014, 5: e01548-14.
    [2]
    He Z, Shao T, Li H, et al. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus[J]. Gut Pathog, 2016, 8: 64. DOI: 10.1186/s13099-016-0146-9
    [3]
    Chen BD, Jia XM, Xu JY, et al. An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus[J]. Arthritis Rheumatol, 2021, 73: 232-243.
    [4]
    Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal[J]. Ann Rheum Dis, 2019, 78: 947-956. DOI: 10.1136/annrheumdis-2018-214856
    [5]
    Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis[J]. Elife, 2013, 2: e01202. DOI: 10.7554/eLife.01202
    [6]
    Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment[J]. Nat Med, 2015, 21: 895-905. DOI: 10.1038/nm.3914
    [7]
    Tang R, Wei Y, Li Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J]. Gut, 2018, 67: 534-541. DOI: 10.1136/gutjnl-2016-313332
    [8]
    Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. DOI: 10.1136/annrheumdis-2016-211064
    [9]
    Mandl T, Marsal J, Olsson P, et al. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity[J]. Arthritis Res Ther, 2017, 19: 237. DOI: 10.1186/s13075-017-1446-2
    [10]
    Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, et al. Connection between the Gut Microbiome, Systemic Inflammation, Gut Permeability and FOXP3 Expression in Patients with Primary Sjögren's Syndrome[J]. Int J Mol Sci, 2020, 21: 8733. DOI: 10.3390/ijms21228733
    [11]
    Zhou C, Zhao H, Xiao XY, et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis[J]. J Autoimmun, 2020, 107: 102360. DOI: 10.1016/j.jaut.2019.102360
    [12]
    Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. DOI: 10.1136/annrheumdis-2016-211064
    [13]
    Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients[J]. Genome Med, 2017, 9: 103. DOI: 10.1186/s13073-017-0490-5
    [14]
    Gomez-Banuelos E, Mukherjee A, Darrah E, et al. Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans[J]. J Clin Med, 2019, 8: 1309. DOI: 10.3390/jcm8091309
    [15]
    Bagavant H, Dunkleberger ML, Wolska N, et al. Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients[J]. Clin Exp Rheumatol, 2019, 37: 106-111.
    [16]
    Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans[J]. Science, 2018, 359: 1156-1161. DOI: 10.1126/science.aar7201
    [17]
    Zegarra-Ruiz DF, El Beidaq A, Iniguez AJ, et al. A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity[J]. Cell Host Microbe, 2019, 25: 113-127. e6. DOI: 10.1016/j.chom.2018.11.009
    [18]
    Ruff WE, Dehner C, Kim WJ, et al. Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity[J]. Cell Host Microbe, 2019, 26: 100-113. e8. DOI: 10.1016/j.chom.2019.05.003
    [19]
    Greiling TM, Dehner C, Chen X, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus[J]. Sci Transl Med, 2018, 10: eaan2306. DOI: 10.1126/scitranslmed.aan2306
    [20]
    Szymula A, Rosenthal J, Szczerba BM, et al. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria[J]. Clin Immunol, 2014, 152: 1-9. DOI: 10.1016/j.clim.2014.02.004
    [21]
    Zhang L, Zhang YJ, Chen J, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review[J]. Microb Pathog, 2018, 117: 49-54. DOI: 10.1016/j.micpath.2018.02.020
    [22]
    Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells[J]. Nature, 2013, 504: 446-450. DOI: 10.1038/nature12721
    [23]
    Sivaprakasam S, Prasad PD, Singh N. Benefits of Short-chain fatty acids and their receptors in inflammation and carcinogenesis[J]. Pharmacol Ther, 2016, 164: 144-151. DOI: 10.1016/j.pharmthera.2016.04.007
    [24]
    Rosser EC, Piper CJM, Matei DE, et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells[J]. Cell Metab, 2020, 31: 837-851. e10. DOI: 10.1016/j.cmet.2020.03.003
    [25]
    Sanchez HN, Moroney JB, Gan H, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids[J]. Nat Commun, 2020, 11: 60. DOI: 10.1038/s41467-019-13603-6
    [26]
    Kidd BA, Ho PP, Sharpe O, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination[J]. Arthritis Res Ther, 2008, 10: R119. DOI: 10.1186/ar2523
    [27]
    Bagavant H, Araszkiewicz AM, Ingram JK, et al. Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies[J]. Front Immunol, 2021, 12: 635072. DOI: 10.3389/fimmu.2021.635072
    [28]
    Hsu TC, Huang CY, Liu CH, et al. Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice[J]. Br J Nutr, 2017, 117: 1066-1074. DOI: 10.1017/S0007114517001039
    [29]
    Yeh YL, Lu MC, Tsai BC, et al. Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice[J]. Probiotics Antimicrob Proteins, 2021, 13: 51-59. DOI: 10.1007/s12602-020-09668-1
    [30]
    Tzang BS, Liu CH, Hsu KC, et al. Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice[J]. Br J Nutr, 2017, 118: 333-342. DOI: 10.1017/S0007114517002112
    [31]
    Li Y, Wang HF, Li X, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus[J]. Clin Sci (Lond), 2019, 133: 821-838. DOI: 10.1042/CS20180841
    [32]
    Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J]. Science, 2018, 359: 91-97. DOI: 10.1126/science.aan3706
    [33]
    Artacho A, Isaac S, Nayak R, et al. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis[J]. Arthritis Rheumatol, 2021, 73: 931-942. DOI: 10.1002/art.41622
    [34]
    Nayak RR, Alexander M, Deshpande I, et al. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation[J]. Cell Host Microbe, 2021, 29: 362-377. e11. DOI: 10.1016/j.chom.2020.12.008
    [35]
    Zaragoza-Garcia O, Castro-Alarcon N, Perez-Rubio G, et al. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy[J]. Biomolecules, 2020, 10: 1479. DOI: 10.3390/biom10111479
    [36]
    Araya RE, Goldszmid RS. Two Bugs a NOD Away from Improving Cancer Therapy Efficacy[J]. Immunity, 2016, 45: 714-716. DOI: 10.1016/j.immuni.2016.10.007
    [37]
    Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis[J]. Genome Med, 2016, 8: 43. DOI: 10.1186/s13073-016-0299-7
    [38]
    Flannigan KL, Taylor MR, Pereira SK, et al. An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil[J]. J Heart Lung Transplant, 2018, 37: 1047-1059. DOI: 10.1016/j.healun.2018.05.002
    [39]
    Taylor MR, Flannigan KL, Rahim H, et al. Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial beta-glucuronidase activity[J]. Sci Adv, 2019, 5: eaax2358. DOI: 10.1126/sciadv.aax2358
    [40]
    Kim DS, Park Y, Choi JW, et al. Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway[J]. Front Immunol, 2021, 12: 696074. DOI: 10.3389/fimmu.2021.696074
    [41]
    Furukawa M, Moriya K, Nakayama J, et al. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis[J]. Hepatol Res, 2020, 50: 840-852. DOI: 10.1111/hepr.13509
    [42]
    Bazin T, Hooks KB, Barnetche T, et al. Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study[J]. Sci Rep, 2018, 8: 5446. DOI: 10.1038/s41598-018-23571-4
    [43]
    Yin J, Sternes PR, Wang M, et al. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition[J]. Ann Rheum Dis, 2020, 79: 132-140. DOI: 10.1136/annrheumdis-2019-215763
    [44]
    Zhou Y, Xu ZZ, He Y, et al. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction[J]. mSystems, 2018, 3: e00188-17.
    [45]
    Aden K, Rehman A, Waschina S, et al. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases[J]. Gastroenterology, 2019, 157: 1279-1292. e11. DOI: 10.1053/j.gastro.2019.07.025
    [46]
    Pan H, Guo R, Ju Y, et al. A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis[J]. Microbiome, 2019, 7: 107. DOI: 10.1186/s40168-019-0719-1
    [47]
    Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial[J]. Int J Rheum Dis, 2016, 19: 869-879. DOI: 10.1111/1756-185X.12888
    [48]
    Alpizar-Rodriguez D, Lesker TR, Gronow A, et al. Prevo-tella copri in individuals at risk for rheumatoid arthritis[J]. Ann Rheum Dis, 2019, 78: 590-593. DOI: 10.1136/annrheumdis-2018-214514
    [49]
    Marietta EV, Murray JA, Luckey DH, et al. Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice[J]. Arthritis Rheumatol, 2016, 68: 2878-2888. DOI: 10.1002/art.39785
    [50]
    Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial[J]. BMC Complement Altern Med, 2010, 10: 1. DOI: 10.1186/1472-6882-10-1
    [51]
    Shokryazdan P, Faseleh Jahromi M, Navidshad B, et al. Effects of prebiotics on immune system and cytokine expression[J]. Med Microbiol Immunol, 2017, 206: 1-9. DOI: 10.1007/s00430-016-0481-y
    [52]
    Wilson B, Eyice O, Koumoutsos I, et al. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms[J]. Nutrients, 2021, 13: 3598. DOI: 10.3390/nu13103598
    [53]
    Ho J, Nicolucci AC, Virtanen H, et al. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes[J]. J Clin Endocrinol Metab, 2019, 104: 4427-4440. DOI: 10.1210/jc.2019-00481
    [54]
    Moro G, Arslanoglu S, Stahl B, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age[J]. Arch Dis Child, 2006, 91: 814-819. DOI: 10.1136/adc.2006.098251
    [55]
    Zeng J, Peng L, Zheng W, et al. Fecal microbiota transplantation for rheumatoid arthritis: A case report[J]. Clin Case Rep, 2020, 9: 906-909.
    [56]
    Kragsnaes MS, Kjeldsen J, Horn HC, et al. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial[J]. BMJ Open, 2018, 8: e019231. DOI: 10.1136/bmjopen-2017-019231
    [57]
    Picchianti Diamanti A, Panebianco C, Salerno G, et al. Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients[J]. Microorganisms, 2020, 8: 1989. DOI: 10.3390/microorganisms8121989
    [58]
    Gutierrez-Diaz I, Fernandez-Navarro T, Sanchez B, et al. Mediterranean diet and faecal microbiota: a transversal study[J]. Food Funct, 2016, 7: 2347-2356. DOI: 10.1039/C6FO00105J
    [59]
    Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal modulates TH17 axis and disease[J]. Nature, 2017, 551: 585-589. DOI: 10.1038/nature24628
    [60]
    Zhang H, Liao X, Sparks JB, et al. Dynamics of gut microbiota in autoimmune lupus[J]. Appl Environ Microbiol, 2014, 80: 7551-7560. DOI: 10.1128/AEM.02676-14
    • Related Articles

  • Related Articles

    [1]QUE Yongtu, LI Pengchong, ZHANG Fengchun. Analysis on Prophylaxis of Pneumocystis Carini Pneumonia by Trimethoprim-Sulfamethoxazole in Patients with Autoimmune Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 196-202. DOI: 10.12290/xhyxzz.2022-0131
    [2]SONG Ziyi, ZHANG Shengxiao, ZHAO Rong, QIAO Jun, SONG Shan, CHENG Ting, WANG Caihong, LI Xiaofeng. Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 821-830. DOI: 10.12290/xhyxzz.2022-0064
    [3]JIANG Xu, YANG Huaxia, ZHANG Fengchun. The Role of the Gut Microbial Metabolites in Autoimmune Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 747-752. DOI: 10.12290/xhyxzz.2022-0246
    [4]WANG Pei, MA Liangkun, LIU Juntao. Difference in Gut Microbiota between the First and the Second Trimester of Pregnancy and the Association of Gut Microbiota with Gestational Diabetes Mellitus: A Prospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 721-728. DOI: 10.12290/xhyxzz.20200122
    [5]Bei-di CHEN, Li-dan ZHAO, Xuan ZHANG. Gut Microbiota and Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 258-263. DOI: 10.3969/j.issn.1674-9081.20200056
    [6]Yu-hao JIAO, Bei-di CHEN, Xuan ZHANG. Interplay between the Gut Microbiota and the Innate Immune System[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 257-262. DOI: 10.3969/j.issn.1674-9081.2019.03.012
    [7]Ying-he LI, Xiang-chen MENG, Peng-guang YAN, Hong YANG, Ji LI, Jia-ming QIAN, Jing-nan LI. Relevance between Glucocorticoid Treatment and the Intestinal Microbiota of Patients with Moderately Severe Ulcerative Colitis: A Single-center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 216-222. DOI: 10.3969/j.issn.1674-9081.2019.03.006
    [8]Xi-nan SHENG, Jun GUO. Current Status and Prospects of the Treatment of Advanced Renal Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 148-151. DOI: 10.3969/j.issn.1674-9081.2019.02.012
    [9]Ying ZHANG, Jin-song GAO, Jun-tao LIU, Hai-yuan LIU, Ying-na SONG, Xiao-ming GONG, Zhi-jing SUN. Effectiveness of B-lynch Suture in Treatment and Prevention of Postpartum Hemorrhage[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 174-177. DOI: 10.3969/j.issn.1674-9081.2013.02.019
    [10]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004

  • Cited by

    Periodical cited type(28)

    1. 李妍，韩彤昕，毛华伟. 线上与线下医学人文教学结合应用的研究与探索. 中国继续医学教育. 2025(01): 185-188 .
    2. 李研，赵琳琳. 英美医学教育中戏剧元素的人文透视. 中国医学伦理学. 2025(03): 385-391 .
    3. 张慧颖，王锦帆，马宇昊，何源. 新时代中国医学人文研究热点及趋势探析. 中国医学伦理学. 2025(03): 336-345 .
    4. 王红宇，刘金强，丁俊杰，王红，孟志剑，唐聚花，张思森. 医患沟通技能培训在急重症医学住院医生规培中的应用. 中国现代医生. 2024(02): 74-76 .
    5. 向琳，王浩辰，黄天宇，何鲲. 基于“医教研德”复合型人才培养模式口腔种植学教学改革思考与探索. 中国医药导报. 2024(04): 70-73 .
    6. 俞婧，王瑞，武云. 基于VOSviewer的我国叙事医学相关文献的可视化分析及启示. 中国毕业后医学教育. 2024(03): 207-213 .
    7. 余航，安琪，金李，吴远，陈涛，肖懿慧. BOPPPS教学模式融合课程思政在本科生内科学见习中的应用. 医学教育研究与实践. 2024(03): 349-354 .
    8. 周殷华，程瑜，崔昌杰，田晓辉，符隆文，方婵，廖晓星，陈起坤. 医文融合视域下临床医学人文教学体系研究. 中国医学伦理学. 2024(07): 860-866 .
    9. 王京，贺欢欣，董智瑞，董健，赵明东. 住培医师人文素养的培育. 中国继续医学教育. 2024(20): 186-189 .
    10. 敖玲敏，沈菊. 中华优秀传统文化融入大学生心理健康教育的价值之维与实践之路. 黑龙江高教研究. 2024(12): 120-126 .
    11. 王倩，巩红，刘昌，李雁，李研，辛娟，张月浪. 以临床人文岗位胜任力为导向的医学人文多元教育渠道的探索. 医学教育研究与实践. 2023(01): 68-72 .
    12. 徐燕玲，顾漪. 临床医师医学人文认知现状调查. 中国现代医生. 2023(05): 135-138 .
    13. 冯悦，庞维，郑丽，李胜军，孙逊，冯辉. 新医科和新文科交叉融合对免疫学创新人才培养的探索性改革. 中国免疫学杂志. 2023(06): 1203-1206 .
    14. 柳舟，张亮，王璐，朱睿瑶，王慧娟，张静，雷佳羲，詹丽英. 重症医学科医学人文素质教育的改革与实践. 中国继续医学教育. 2023(12): 10-14 .
    15. 阳磊，彭蓓，张婉丽. 口腔科住院医师规范化培训医学人文教育改革实践. 经济研究导刊. 2023(12): 123-125 .
    16. 赵娟，徐斌. 进修医师自身免疫性肝炎临床带教体会. 继续医学教育. 2023(06): 129-132 .
    17. 刘琴，何自强，骆佳佳，冯凯娜. 以提升人文关怀能力为导向的护理学导论教学模式应用研究. 沈阳医学院学报. 2023(05): 540-543 .
    18. 谢佳君，何勇涛，黄国琼，秦宇彤，王方芳，栗昕，黄春基. 立德树人背景下医学生德育素质培养研究. 中国社会医学杂志. 2023(05): 540-543 .
    19. 吕晓龙，严旭，章涵. 以强化人文素养为导向的全科医学生叙事医学课程模式构建. 济源职业技术学院学报. 2023(04): 33-37 .
    20. 吕少春，宋汉君，栾海艳，何穆涵. 基于医学模拟教学的医学生临床能力培养研究. 医学教育研究与实践. 2022(03): 294-297 .
    21. 李超. 培养高素质临床医生路径分析. 继续医学教育. 2022(04): 61-64 .
    22. 冯矗，陈飞，张树霞，刘古月，李晓宇. 医学人文关怀教育融入外科实习的实践探索. 中医药管理杂志. 2022(11): 88-90 .
    23. 高铭，韩涛，池靖涵，杜振兰，杨常栓，侯豫，花少栋. 创新互动式医学人文教育在儿科住院医师规范化培训中的作用研究. 中国医学伦理学. 2022(07): 806-810 .
    24. 胡艳超，王洪涛，王怡雯，周戬平. 医学人文教育在心血管内科混合式教学中的应用. 医学教育研究与实践. 2022(05): 648-652 .
    25. 叶榆莹. 英语电影字幕翻译对医学生人文教育的作用探究. 才智. 2022(33): 62-65 .
    26. 陶庆才. 抗疫精神融入医学院校课程思政的研究与实践. 浙江医学教育. 2022(05): 268-270+299 .
    27. 张宏伟，熊梓彤，林芷伊. 英国医学人文关怀及其医学教育启示. 农垦医学. 2022(06): 561-564 .
    28. 祝贺，敖俊红，杨蓉娅，李海涛. 全媒体时代医学摄影的边界教育在皮肤病与性病科临床教学中的意义. 实用皮肤病学杂志. 2022(06): 367-369 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3940) PDF downloads (88) Cited by(34)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close